NPS Pharmaceuticals, Inc. Company Profile

Description: NPS Pharmaceuticals, Inc.

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of specialty therapeutics for gastrointestinal and endocrine disorders. The company is advancing two late-stage programs to restore or replace biological function, including GATTEX (teduglutide), which is in Phase 3 clinical development for parenteral dependent short bowel syndrome; and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) that is in Phase 3 clinical development as a hormone therapy for hypoparathyroidism. It has collaboration and license agreements with Amgen Inc.; AstraZeneca AB; GlaxoSmithKline; Kyowa Kirin; Nycomed; Ortho-McNeil Pharmaceuticals, Inc.; Hoffman-La Roche Inc.; and F. Hoffmann-La Roche Ltd. The company was founded in 1986 and is based in Bedminster, New Jersey.

Company Profile

$125.00

 

 NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on the development of specialty therapeutics for the treatment of gastrointestinal and endocrine disorders. The company is in the process of developing two late-stage programs ...

Close Viewer

$24.95

 

 NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on the development of new treatment options for patients with gastrointestinal and endocrine disorders and medical needs. NPS clinical programs involve two therapeutic peptides...

Close Viewer

Cart Summary

Cart items will instantly download upon purchase.

There are no items in your cart
Your Savings: $0.00
Your Total: $0.00

Contact Info

Address:
550 Hills Drive, 3rd Floor, Bedminster,NJ 07921, United States
Phone:
908-450-5300
Revenue:
86.49M
Employees:
53
Website:
http://www.npsp.com

Executive Team

Dr. Francois Nader MD, MBA
51, Chief Exec. Officer, Pres
Mr. Luke M. Beshar CPA
51, Chief Financial Officer, Principal Accounting Officer and Sr. VP
Dr. Roger J. Garceau M.D., FAAP
56, Chief Medical Officer and Sr. VP of R&D
Mr. Edward H. Stratemeier J.D., MBA
61, Sr. VP, Gen. Counsel and Corp. Sec.
Ms. Sandra C. Cottrell MA PhD
61, VP of Regulatory Affairs & Drug Safety

Competitors

ABT
Abbott Laboratories
BIIB
Biogen Idec Inc.